181 related articles for article (PubMed ID: 20821246)
1. Gene delivery of soluble vascular endothelial growth factor receptor-1 (sFlt-1) inhibits intra-plaque angiogenesis and suppresses development of atherosclerotic plaque.
Wang Y; Zhou Y; He L; Hong K; Su H; Wu Y; Wu Q; Han M; Cheng X
Clin Exp Med; 2011 Jun; 11(2):113-21. PubMed ID: 20821246
[TBL] [Abstract][Full Text] [Related]
2. Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo.
Ramachandra S; D'Souza SS; Gururaj AE; Shaila MS; Salimath BP
J Gene Med; 2009 May; 11(5):422-34. PubMed ID: 19266483
[TBL] [Abstract][Full Text] [Related]
3. Ghrelin inhibits atherosclerotic plaque angiogenesis and promotes plaque stability in a rabbit atherosclerotic model.
Wang L; Chen Q; Ke D; Li G
Peptides; 2017 Apr; 90():17-26. PubMed ID: 28189525
[TBL] [Abstract][Full Text] [Related]
4. Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis.
Kim WJ; Yockman JW; Lee M; Jeong JH; Kim YH; Kim SW
J Control Release; 2005 Aug; 106(1-2):224-34. PubMed ID: 15970348
[TBL] [Abstract][Full Text] [Related]
5. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
[TBL] [Abstract][Full Text] [Related]
6. [In vitro study of human multiple myeloma cell transfected with soluble vascular endothelial growth factor receptor-1 gene].
Zheng D; Li J; Liu JR; Zhou ZH; Gu JL
Chin J Cancer; 2010 Jan; 29(1):65-8. PubMed ID: 20038313
[TBL] [Abstract][Full Text] [Related]
7. [Construction and expression of soluble vascular endothelial growth factor receptor-1 eukaryotic expression vector and its effect on proliferation of vascular endothelial cells].
Ji L; Mao S; Liu H; Xu S; Yang Y; Yi C; Huang Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Apr; 27(2):369-72. PubMed ID: 20481321
[TBL] [Abstract][Full Text] [Related]
8. Soluble Flt-1 gene delivery in acute myeloid leukemic cells mediating a nonviral gene carrier.
Amini R; Azizi Jalilian F; Veerakumarasivam A; Abdullah S; Abdulamir AS; Nadali F; Rosli R
Biomed Res Int; 2013; 2013():752603. PubMed ID: 23509773
[TBL] [Abstract][Full Text] [Related]
9. sFlt-1 gene therapy of follicular thyroid carcinoma.
Ye C; Feng C; Wang S; Wang KZ; Huang N; Liu X; Lin Y; Li M
Endocrinology; 2004 Feb; 145(2):817-22. PubMed ID: 14605010
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor and soluble FLT-1 receptor interactions and biological implications.
Malecki M; Trembacz H; Szaniawska B; Przybyszewska M; Janik P
Oncol Rep; 2005 Dec; 14(6):1565-9. PubMed ID: 16273257
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor-2/platelet-derived growth factor enhances atherosclerotic plaque stability.
Mao Y; Liu XQ; Song Y; Zhai CG; Xu XL; Zhang L; Zhang Y
J Cell Mol Med; 2020 Jan; 24(1):1128-1140. PubMed ID: 31755222
[TBL] [Abstract][Full Text] [Related]
12. Silent Information Regulator 1 Negatively Regulates Atherosclerotic Angiogenesis via Mammalian Target of Rapamycin Complex 1 Signaling Pathway.
Chen R; Huang Z; Wang J; Chen X; Fu Y; Wang W
Am J Med Sci; 2018 Aug; 356(2):168-176. PubMed ID: 30219159
[TBL] [Abstract][Full Text] [Related]
13. Panax notoginseng saponins inhibits atherosclerotic plaque angiogenesis by down-regulating vascular endothelial growth factor and nicotinamide adenine dinucleotide phosphate oxidase subunit 4 expression.
Qiao Y; Zhang PJ; Lu XT; Sun WW; Liu GL; Ren M; Yan L; Zhang JD
Chin J Integr Med; 2015 Apr; 21(4):259-65. PubMed ID: 24599820
[TBL] [Abstract][Full Text] [Related]
14. [Effect of soluble vascular endothelial growth factor (VEGF) receptor gene (sflt-1) and antisense VEGF nucleotide on neovascularization].
Mi J; Wang JH; Chen SS
Ai Zheng; 2002 May; 21(5):464-8. PubMed ID: 12452033
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization.
Lai CM; Brankov M; Zaknich T; Lai YK; Shen WY; Constable IJ; Kovesdi I; Rakoczy PE
Hum Gene Ther; 2001 Jul; 12(10):1299-310. PubMed ID: 11440623
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study of human colon cell line Lovo transfected with soluble vascular endothelial growth factor receptor 1 gene].
Zheng CX; Wu RY; Chen LH; Tan M
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):416-9. PubMed ID: 19598033
[TBL] [Abstract][Full Text] [Related]
17. Impact of the transfer of sFlt-1 gene fragments on the ERK1/2 pathway of VEGF in vitro.
Jiang D; Gu H; Wu Q; Wang X; Zhang M; Song B
Curr Eye Res; 2009 Sep; 34(9):800-8. PubMed ID: 19839874
[TBL] [Abstract][Full Text] [Related]
18. Suppression of ovarian cancer by muscle-mediated expression of soluble VEGFR-1/Flt-1 using adeno-associated virus serotype 1-derived vector.
Takei Y; Mizukami H; Saga Y; Yoshimura I; Hasumi Y; Takayama T; Kohno T; Matsushita T; Okada T; Kume A; Suzuki M; Ozawa K
Int J Cancer; 2007 Jan; 120(2):278-84. PubMed ID: 17066424
[TBL] [Abstract][Full Text] [Related]
19. Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularization.
Owen LA; Uehara H; Cahoon J; Huang W; Simonis J; Ambati BK
PLoS One; 2012; 7(3):e33576. PubMed ID: 22438952
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model.
Hu M; Yang JL; Teng H; Jia YQ; Wang R; Zhang XW; Wu Y; Luo Y; Chen XC; Zhang R; Tian L; Zhao X; Wei YQ
BMC Cancer; 2008 Oct; 8():306. PubMed ID: 18947384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
